UNSPSC 51372101: Acetyldihydrocodeine

This classification denotes an opioid receptor agonist with the molecular formula C20H25NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SGY1T84P34, chemically known as 7,8-dihydrocodeine acetate but generally known as acetyldihydrocodeine, which bears US NIH Compound Identifier 5463874. European Medicines Agency schedules Acetyldihydrocodeine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12719MIG.

World Health Organization schedules acetyldihydrocodeine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule acetyldihydrocodeine under HS 29391900 and SITC 54141. As of Q4 2014, ACETYLDIHYDROCODEINE remains the US FDA Preferred Term for this commodity. SMILES: O1C2C34C(C(N(CC3)C)CC3C4C1C(OC)CC3)CCC2OC(=O)C.

UNSPSC 51372101 Acetyldihydrocodeine is a Commodity code that nominally describes a specific opioid pharmaceutical, but the recent state and local procurement activity tagged under it reflects a substantial mismatch: Seminole County, Florida solicited naloxone and drug deactivation systems—harm-reduction and overdose-reversal products with fundamentally different therapeutic purpose and regulatory classification than acetyldihydrocodeine. The code shows no recent activity aligned with its stated pharmaceutical scope; the single posted opportunity appears to be a classification error rather than representative procurement of acetyldihydrocodeine itself. State and local health departments, county health agencies, and public health authorities are the issuing bodies most likely to procure controlled substances or pharmaceutical supplies, though the sparse activity record here suggests either low-volume purchasing, centralized procurement through state formularies or group purchasing organizations, or consistent misclassification in the taxonomy.

Seminole County, Florida represents the only identifiable recent activity under this code. The county issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023 (note: the posted and due dates are misaligned in the source). Bidders were required to submit electronic bids through the county's e-Procurement Portal with all shipping and delivery costs included, comply with E-Verify and drug-free workplace certification, and maintain workers' compensation and general liability insurance. The contract carried a two-year initial term with a one-year renewal option and included a three-month probationary termination clause. Without additional opportunities in the record or geographic concentration across other jurisdictions, this code does not present a reliable signal for ongoing business development targeting acetyldihydrocodeine or related controlled pharmaceutical procurement at the state and local level.